4-Hydroxypiperidine - CAS 5382-16-1
Catalog: |
BB028357 |
Product Name: |
4-Hydroxypiperidine |
CAS: |
5382-16-1 |
Synonyms: |
piperidin-4-ol |
IUPAC Name: | piperidin-4-ol |
Description: | Used as a reagent for the synthesis of acridine (A190900) derivatives and fibrinogen receptor antagonists. |
Molecular Weight: | 101.15 |
Molecular Formula: | C5H11NO |
Canonical SMILES: | C1CNCCC1O |
InChI: | InChI=1S/C5H11NO/c7-5-1-3-6-4-2-5/h5-7H,1-4H2 |
InChI Key: | HDOWRFHMPULYOA-UHFFFAOYSA-N |
Boiling Point: | 108-114 °C (10 mmHg) |
Density: | 1.016 g/cm3 |
Appearance: | Hygroscopic solid |
MDL: | MFCD00005999 |
LogP: | 0.05950 |
GHS Hazard Statement: | H314 (22.67%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P261, P264, P271, P280, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P312, P321, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113307779-A | Heterocyclic substituted biphenyl compound, preparation method and application | 20210525 |
CN-113292503-A | Preparation method of 2-bromo-3-aminonaphthoquinone compound | 20210522 |
CN-113372263-A | Preparation method of 2-chloro-3-aminonaphthoquinone compound | 20210521 |
CN-113200956-A | Sulfabenzamide derivative and preparation method and application thereof | 20210518 |
CN-113121467-A | Benzothiazole derivative and medical application thereof | 20210420 |
PMID | Publication Date | Title | Journal |
22293844 | 20120131 | Synthesis of novel IP agonists via N-aminoethyl cyclic amines prepared by decarboxylative ring-opening reactions | Molecules (Basel, Switzerland) |
22050275 | 20111201 | Characterisation of Plasmodium falciparum aspartic protease inhibition by piperidine derivatives | Natural product research |
21837116 | 20110701 | 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium 2-(2-phenyl-eth-yl)benzoate | Acta crystallographica. Section E, Structure reports online |
20947616 | 20110101 | A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5 | Drug metabolism and disposition: the biological fate of chemicals |
21094047 | 20110101 | 2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice | Bioorganic & medicinal chemistry letters |
Complexity: | 50 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 101.084063974 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 101.084063974 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 32.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS